Search every filing
2,477,667 paragraphs from 10-Ks, 10-Qs and 8-Ks with press releases.
Matching paragraphs
additional tariff increases proposed but currently on pause. Some countries have imposed retaliatory tariffs and
Read in the filing ↗ Also in 10-Q of Nov 4, 2025
invalidation in the Supreme Court of many of the tariffs. Some countries have imposed retaliatory tariffs
Read in the filing ↗
The U.S. has adopted new and increased tariffs on imports from countries, and such tariffs remain subject
Read in the filing ↗ Also in 10-Q of May 5, 2026
The U.S. has adopted new and increased tariffs on imports from countries, which tariffs remain subject to
Read in the filing ↗ Also in 10-Q of May 5, 2026
the Supreme Court of many of the tariffs. Some countries have imposed retaliatory tariffs and other restrictions on
Read in the filing ↗ Also in 10-Q of May 5, 2026
imposition of (and the potential for additional) tariffs by the U.S. on numerous countries and retaliatory tariffs;
Read in the filing ↗ Also in 10-Q of Aug 4, 2026
invalidation in the Supreme Court of many of the tariffs, such as IEEPA tariffs, on February 20, 2026.
Read in the filing ↗
Emergency Economic Powers Act (IEEPA) tariff refunds recognized during the period.
Read in the filing ↗
generally consistent with current levels and that additional tariffs will not be introduced.
Read in the filing ↗
unexpected difficulties in importing or exporting our products and import/export tariffs, quotas,
Read in the filing ↗
unexpected difficulties in importing or exporting our products and import/export tariffs, quotas, sanctions
Read in the filing ↗
numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated litigation
Read in the filing ↗ Also in 10-Q of Nov 4, 2025, 10-K of Feb 24, 2026
levels, that the effects of tariffs can be mitigated, and includes remeasurement gains related
Read in the filing ↗
the current imposition of (and the potential for additional) tariffs by the U.S.
Read in the filing ↗
challenges. Although the U.S. Supreme Court invalidated certain tariffs imposed under the International
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
Emergency Economic Powers Act (IEEPA), the U.S. government has subsequently implemented additional tariff
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
trade, tariffs and sanctions, or greater restrictions on imports and exports; supply chain disruption; geopolitical
Read in the filing ↗
levels, that the effects of tariffs can be mitigated, and includes expected remeasurement gains related
Read in the filing ↗
countries over tariff rates and other trade policies. These developments, and anticipated future developments, have
Read in the filing ↗ Also in 10-Q of Nov 4, 2025
dental equipment from market uncertainty related to tariffs. The decrease was partially offset by dental
Read in the filing ↗
uncertainty related to tariffs in the second half of the quarter ended June 28, 2025.
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
million, respectively, related to previously paid IEEPA tariffs. We expect to recognize additional benefit from
Read in the filing ↗
governing foreign trade, tariffs and sanctions or greater restrictions on imports and exports, including changes to
Read in the filing ↗ Also in 10-Q of Nov 4, 2025, 10-K of Feb 24, 2026
Medicaid programs. The OBBBA, in combination with tariffs, will almost certainly have an adverse impact on
Read in the filing ↗
programs. The OBBBA, in combination with tariffs, will almost certainly have an adverse impact on utilization,
Read in the filing ↗
programs. The OBBBA, in combination with tariffs, will likely have an adverse impact on utilization, Medicaid
Read in the filing ↗
Some countries have imposed retaliatory tariffs and other restrictions on imports from the U.S. These
Read in the filing ↗
basis for these tariffs continue to evolve through legislative and executive actions, exemptions and ongoing judicial
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
and policies governing foreign trade, tariffs and sanctions or greater restrictions on imports and exports, including
Read in the filing ↗
wider European or global conflict); changes to laws and policies governing foreign trade, tariffs and sanctions or
Read in the filing ↗ Also in 10-Q of Aug 4, 2026
See Exhibit D for a summary of Net Acquisition Related Fair Value Adjustments and Net Tariff Refunds
Read in the filing ↗
changes to international trade agreements and the current imposition of (and the potential for additional) tariffs by
Read in the filing ↗ Also in 8-K of Aug 5, 2025
the U.S. on numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated
Read in the filing ↗
refunds of certain IEEPA tariffs previously paid in the United States. Interest expense increased primarily due to
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
The U.S. has adopted new and increased tariffs on imports from countries, subject to evolving exemptions, with
Read in the filing ↗ Also in 10-Q of Nov 4, 2025
year, although sales of U.S. dental equipment were temporarily impacted by market uncertainty related to tariffs in
Read in the filing ↗
tariffs on numerous countries that are incrementally higher than those in place today will take effect, the exceptions
Read in the filing ↗
uncertainty related to tariffs. The decrease was partially offset by dental equipment sales growth in certain of our
Read in the filing ↗
experienced increased costs due to labor cost increases, source of supply, and tariffs, which may have had a
Read in the filing ↗
unclear whether, or the extent to which, the current tariffs on trade with numerous countries will remain in
Read in the filing ↗
tariffs on trade with numerous countries will remain in place, or change, the exceptions that may apply, and
Read in the filing ↗
countries have imposed, or may impose, retaliatory tariffs or other restrictions on imports from the U.S. These
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
The Company’s FY2026 non-GAAP diluted EPS guidance includes the net benefit from tariff refunds recognized in
Read in the filing ↗
Management presents adjusted non-GAAP diluted EPS excluding net tariff refund benefits and remeasurement gains as we believe
Read in the filing ↗
Services segment, we recognized a net benefit of $20 million related to refunds for certain IEEPA tariffs previously
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
Specialty Products segment, we recognized a net benefit of $8 million related to refunds for certain IEEPA tariffs
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
changes to laws and policies governing foreign trade, tariffs and sanctions or greater restrictions on imports and exports, including
Read in the filing ↗
international trade agreements and the current imposition of (and the potential for additional) tariffs by the U.S. on
Read in the filing ↗ Also in 10-Q of Nov 4, 2025, 10-K of Feb 24, 2026
and the impact on U.S. dental equipment from market uncertainty related to tariffs. For the three months ended
Read in the filing ↗
current tariffs on trade with numerous countries will remain in place, or change, the exceptions that may apply, and
Read in the filing ↗
to which, the current tariffs on trade with numerous countries will remain in place, or change, the exceptions that
Read in the filing ↗ Also in 10-Q of May 5, 2026
U.S. dental equipment were temporarily impacted by market uncertainty related to tariffs in the second half of the
Read in the filing ↗ Also in 10-Q of May 5, 2026
foreign trade, tariffs and sanctions or greater restrictions on imports and exports, including changes to international trade agreements and
Read in the filing ↗
The U.S. has adopted new and increased tariffs on imports from countries, and the scope, applicability and legal
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
trade policies with individual countries. It is unclear whether, or the extent to which, the current tariffs on trade
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
The tariffs did not have a material impact on our results of operations during fiscal year 2025, although sales of
Read in the filing ↗ Also in 10-Q of May 5, 2026
quarter ended June 28, 2025. It is unclear whether, or the extent to which, the current tariffs on trade with
Read in the filing ↗
During the three and six months ended June 27, 2026 we received an immaterial amount of refunds of certain tariffs
Read in the filing ↗
previously paid in the United States. In addition to the benefit of the tariff refunds, the increase in gross margin
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
The tariffs did not have an adverse material impact on our results of operations during fiscal year 2025 and the six
Read in the filing ↗
The tariffs did not have an adverse material impact on our results of operations during fiscal year 2025 and the nine
Read in the filing ↗
paid in the United States. In addition to the benefit of the tariff refunds, the increase in gross margin rates was
Read in the filing ↗ Also in 10-Q of Nov 3, 2026
The tariffs did not have a material impact on our results of operations in the first or second quarter of this fiscal
Read in the filing ↗
The tariffs did not have a material impact on our results of operations in the first, second, or third quarter of this
Read in the filing ↗
tariffs in the second half of the quarter ended June 28, 2025. It is unclear whether, or the extent to which, the
Read in the filing ↗
including changes to international trade agreements and the current imposition of (and the potential for additional) tariffs by the U.S. on numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated litigation developments and the status of litigation matters; our dependence on our senior management (including, without limitation, succession planning for our Chief Executive Officer), employee hiring and retention, increases in labor costs or health care costs, and our relationships with customers, suppliers and manufacturers; and disruptions in financial markets. The order in which these factors appear should not be construed to indicate their relative importance or priority.
Read in the filing ↗
… on numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated litigation developments and the status of litigation matters; our dependence on our senior management (including, without limitation, the transition to a new CEO), employee hiring and retention, increases in labor costs or health care costs, and our relationships with customers, suppliers and manufacturers; and disruptions in …
Read in the filing ↗
… on numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated litigation developments and the status of litigation matters; our dependence on our senior management, employee hiring and retention, increases in labor costs or health care costs, and our relationships with customers, suppliers and manufacturers; and disruptions in financial markets. The order in which these factors appear …
Read in the filing ↗
… on numerous countries and retaliatory tariffs; supply chain disruption; litigation risks; new or unanticipated litigation developments and the status of litigation matters; our dependence on our senior management, employee hiring and retention, increases in labor costs or health care costs, and our relationships with customers, suppliers and manufacturers; and disruptions in financial markets. The order in which these factors appear …
Read in the filing ↗
… outbreak of war (including, without limitation, geopolitical wars), terrorism or public unrest (including, without limitation, the war in Ukraine, the Israel-Gaza war and other unrest and threats in the Middle East and the possibility of a wider European or global conflict); changes to laws and policies governing foreign trade, tariffs and sanctions or greater restrictions on imports and exports,
Read in the filing ↗